Get the Stockscreener App
2.75
3.51%
-0.10
After Hours:
2.76
0.010
+0.36%
Sonoma Pharmaceuticals Inc stock is traded at $2.75, with a volume of 8,682.
It is down -3.51% in the last 24 hours and down -19.83% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$2.85
Open:
$2.83
24h Volume:
8,682
Relative Volume:
0.42
Market Cap:
$4.76M
Revenue:
$14.91M
Net Income/Loss:
$-3.56M
P/E Ratio:
-1.1182
EPS:
-2.4593
Net Cash Flow:
$-1.37M
1W Performance:
-10.13%
1M Performance:
-19.83%
6M Performance:
-8.33%
1Y Performance:
+8.27%
1-Day Range:
$2.69
$2.85
1-Week Range:
$2.69
$3.16
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
2.75 | 4.93M | 14.91M | -3.56M | -1.37M | -2.4593 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.37 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.64 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.92 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
476.13 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results - ACCESS Newswire
Can Sonoma Pharmaceuticals Inc. maintain its current growth rateJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - mfd.ru
Scar Treatment Market Expected See Incredible Growth - openPR.com
Fierce Biotech Layoff Tracker 2026: ARPA-H makes cuts; GSK trims R&D team - Fierce Biotech
Treatment Type Analysis - Market.us
Sonoma Pharmaceuticals appoints new board member and senior executive By Investing.com - Investing.com Nigeria
Sonoma Pharmaceuticals appoints new board member and senior executive - Investing.com
Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development - ACCESS Newswire
Momentum Shift: Is Bristow Group Inc showing insider buyingMarket Sentiment Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Layoff Tracker: Takeda Slashes US Headcount, Hitting Neuro Commercial Teams Hard - BioSpace
Fed Watch: Can Sonoma Pharmaceuticals Inc expand into new marketsWeekly Trend Recap & Smart Investment Allocation Tips - baoquankhu1.vn
Aug Reactions: Can Tavia Acquisition Corp Equity Right navigate macro headwindsMarket Growth Review & Low Drawdown Investment Strategies - baoquankhu1.vn
Earnings Miss: Can Sonoma Pharmaceuticals Inc expand into new marketsQuarterly Investment Review & Stepwise Trade Execution Plans - baoquankhu1.vn
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Could Be Riskier Than It Looks - Sahm
Momentum Shift: Will Sonoma Pharmaceuticals Inc stock go up in YEARIPO Watch & Weekly Sector Rotation Insights - baoquankhu1.vn
Sonoma Pharmaceuticals, Inc. Updates Investor Presentation - TradingView — Track All Markets
Aug Intraday: Is Sonoma Pharmaceuticals Inc stock forming a cup and handle2025 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Retail Trends: What dividend safety score for Sonoma Pharmaceuticals Inc stockWeekly Trade Report & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Aug Breakouts: How geopolitical tensions affect Sonoma Pharmaceuticals Inc. stockProfit Target & Verified High Yield Trade Plans - ulpravda.ru
What dividend safety score for Sonoma Pharmaceuticals Inc. stockBest Sellers Snapshot & size guide reminders to avoid returns - ulpravda.ru
What catalysts could drive Sonoma Pharmaceuticals Inc. stock higher2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - Улправда
Is Sonoma Pharmaceuticals Inc. stock resilient to inflationJuly 2025 Market Mood & Community Trade Idea Sharing Platform - Улправда
Aug Spikes: What hedge fund activity signals for Sonoma Pharmaceuticals Inc. stockWall Street Watch & Free Long-Term Investment Growth Plans - ulpravda.ru
Will Sonoma Pharmaceuticals Inc. stock beat EPS estimates2025 Sector Review & Verified Stock Trade Ideas - Улправда
How geopolitical tensions affect Sonoma Pharmaceuticals Inc. stockMarket Sentiment Report & AI Based Buy/Sell Signal Reports - ulpravda.ru
Published on: 2026-01-08 01:30:55 - Улправда
Sonoma Pharmaceuticals Shares Soar After Diaper Rash Product Hits Major Retailers - MSN
Why Sonoma Pharmaceuticals Inc. (O8Z) stock is trending on social media2026 world cup usa national team quarterfinals top scorers transition play knockout prediction preview - ulpravda.ru
Head to Head Comparison: Ocular Therapeutix (NASDAQ:OCUL) & Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
Sonoma Pharmaceuticals issues annual equity grants to executives and directors - Investing.com Nigeria
Sonoma Pharmaceuticals issues annual equity grants to executives and directors By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals (SNOA) awards 5,000 RSUs to Controller Dal Poggetto - Stock Titan
EFC recently clinched a ₹183 cr interior turnkey fit‑out project with a major Indian MNCMarket Entry Points & Budget Friendly Growth - bollywoodhelpline.com
Shilchar Technologies Limited Trading Near Value Zone — Recovery AheadResistance Breakout Alerts & Explosive Capital Gains - bollywoodhelpline.com
Fundamentals Check: Will Sonoma Pharmaceuticals Inc. stock benefit from M&A activity2025 Bull vs Bear & Precise Buy Zone Identification - moha.gov.vn
Intraday Charts Show Spike in Vineet Laboratories Limited ActivityLow Beta Stocks & Low Cost Market Tips - Bollywood Helpline
Sonoma Pharmaceuticals Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Why Sonoma Pharmaceuticals Inc. stock could see breakout soonJuly 2025 Recap & Consistent Profit Trade Alerts - DonanımHaber
Is Sonoma Pharmaceuticals Inc. stock attractive for growth ETFs2025 Market WrapUp & Weekly High Return Forecasts - DonanımHaber
Published on: 2025-12-18 21:37:00 - Улправда
Dividend Income and re investment StrategyInterest Rate Changes & Discover Top Gainers in Every Sector - Bollywood Helpline
Demand for Scar Treatment in UK | Global Market Analysis Report2035 - Fact.MR
What analysts say about Sonoma Pharmaceuticals Inc stockMoving Average Strategies & Free Real-Time Trading Alerts Every Day - earlytimes.in
What analysts say about Sonoma Pharmaceuticals Inc O8Z stockConsumer Goods Stocks & Low Risk Trading Plans - earlytimes.in
Sonoma Pharmaceuticals (SNOA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Sonoma Pharmaceuticals Inc. (O8Z) stock appeals to dividend investorsWeekly Stock Recap & Real-Time Volume Surge Alerts - Newser
How Sonoma Pharmaceuticals Inc. (O8Z) stock compares with tech leadersJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser
Sonoma Pharmaceuticals, Inc. (SNOA) 10.6% in After-hours: Strong Surge Amid Routine Trading - Stocks Telegraph
What drives Sonoma Pharmaceuticals Inc stock priceAnalyst Downgrades & Free High Return Strategy Alerts - earlytimes.in
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.70%
10.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):